Xin Yu
12Patents
3h-index
21Co-inventors
52Inventor score
Filing activity: Oct 9, 2012 → Dec 18, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9499596B2 | Compositions and methods for the treatment of immune related diseases | Emerging Cross-Sectional Technologies | 39 | Active |
| US9873740B2 | Methods of treating cancer using PD-1 axis binding antagonists and TIGIT inhibitors | Emerging Cross-Sectional Technologies | 18 | Active |
| US10221133B2 | (Thio, oxo, and seleno) semicarbazone complexes with zinc and their use for treating cancer | Chemistry; Metallurgy | 4 | Active |
| US10626174B2 | Methods of treating cancer using PD-1 axis binding antagonists and TIGIT inhibitors | Emerging Cross-Sectional Technologies | 3 | Active |
| US10604481B2 | (Thio, oxo and seleno) semicarbazone complexes with zinc and their use for treating cancer | Chemistry; Metallurgy | 2 | Active |
| US10729671B2 | Zinc complexes of hydrazones and (thio)semicarbazones and their use for the treatment of cancer | Chemistry; Metallurgy | 2 | Active |
| US10828288B2 | Hydrazone derivatives for the treatment of cancer | Chemistry; Metallurgy | 2 | Active |
| US10611836B2 | Methods of treating cancer using PD-1 axis binding antagonists and tigit inhibitors | Emerging Cross-Sectional Technologies | 2 | Active |
| US10604480B2 | (Thio, oxo, and seleno) semicarbazone derivatives and their use for treating cancer | Chemistry; Metallurgy | 2 | Active |
| US10377823B2 | Compositions and methods for the treatment of immune related diseases | General | 0 | Revoked |
| US11390678B2 | Compositions and methods for the treatment of immune related diseases | Emerging Cross-Sectional Technologies | 0 | Active |
| US11926672B2 | Mesothelin-targeted CD40 agonistic multispecific antibody constructs for the treatment of solid tumors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.